Concerns over new anti-malaria drug fast-tracked by FDA

Now, a new anti-malarial drug called tafenoquine is being fast-tracked for approval by the Food and Drug Administration, according to one of its developers. That’s raised some serious concerns among service members from as far away as Australia.

Andrea McCarren, Concerns over new anti-malatia drug fast-tracked by FDA, WUSA9, 5/24/18